Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cesamet in Fibromyalgia
NCT00272207Phase 2Completed
- Sponsor
- Winnipeg Regional Health Authority
- Start
- Apr 2006
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of nabilone in fibromyalgia (FM), sponsored by Winnipeg Regional Health Authority. Primary endpoints: Visual Analogue Scale Pain at 8 weeks and Number of Tender Points at 8 weeks. Started Apr 2006; status: completed.
02
Drugs
nabilone
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT00272207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00272207.